Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity

Background: In chronic inflammatory demyelinating polyneuropathy (CIDP), there is an urgent need for biomarkers to monitor ongoing disease activity. Serum calprotectin (CLP) induces signaling pathways involved in inflammatory processes and has been shown to correlate with markers of disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Stascheit, Frauke, Hotter, Benjamin, Klose, Sarah, Meisel, Christian, Meisel, Andreas, Klehmet, Juliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473624/
https://www.ncbi.nlm.nih.gov/pubmed/34589050
http://dx.doi.org/10.3389/fneur.2021.723009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473624/
https://www.ncbi.nlm.nih.gov/pubmed/34589050
http://dx.doi.org/10.3389/fneur.2021.723009

Ejemplares similares